RSCF
Price
$0.05
Change
-$0.01 (-16.67%)
Updated
Sep 5 closing price
Capitalization
4.69M
RSMDF
Price
$16.63
Change
+$0.06 (+0.36%)
Updated
Aug 12 closing price
Capitalization
40.56B
47 days until earnings call
Interact to see
Advertisement

RSCF vs RSMDF

Header iconRSCF vs RSMDF Comparison
Open Charts RSCF vs RSMDFBanner chart's image
Reflect Scientific
Price$0.05
Change-$0.01 (-16.67%)
Volume$541.37K
Capitalization4.69M
Resmed
Price$16.63
Change+$0.06 (+0.36%)
Volume$159
Capitalization40.56B
RSCF vs RSMDF Comparison Chart in %
Loading...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCF vs. RSMDF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCF is a Hold and RSMDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (RSCF: $0.05 vs. RSMDF: $16.57)
Brand notoriety: RSCF and RSMDF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RSCF: 995% vs. RSMDF: 3%
Market capitalization -- RSCF: $4.69M vs. RSMDF: $40.56B
RSCF [@Pharmaceuticals: Other] is valued at $4.69M. RSMDF’s [@Pharmaceuticals: Other] market capitalization is $40.56B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCF’s FA Score shows that 1 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • RSCF’s FA Score: 1 green, 4 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RSMDF is a better buy in the long-term than RSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCF’s TA Score shows that 4 TA indicator(s) are bullish while RSMDF’s TA Score has 5 bullish TA indicator(s).

  • RSCF’s TA Score: 4 bullish, 5 bearish.
  • RSMDF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RSMDF is a better buy in the short-term than RSCF.

Price Growth

RSCF (@Pharmaceuticals: Other) experienced а -8.83% price change this week, while RSMDF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

RSMDF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($40.6B) has a higher market cap than RSCF($4.69M). RSCF YTD gains are higher at: 30.238 vs. RSMDF (-27.058). RSMDF has higher annual earnings (EBITDA): 1.92B vs. RSCF (8.86K). RSMDF has more cash in the bank: 1.21B vs. RSCF (1.3M). RSCF has less debt than RSMDF: RSCF (141K) vs RSMDF (852M). RSMDF has higher revenues than RSCF: RSMDF (5.15B) vs RSCF (1.72M).
RSCFRSMDFRSCF / RSMDF
Capitalization4.69M40.6B0%
EBITDA8.86K1.92B0%
Gain YTD30.238-27.058-112%
P/E RatioN/A17.49-
Revenue1.72M5.15B0%
Total Cash1.3M1.21B0%
Total Debt141K852M0%
FUNDAMENTALS RATINGS
RSCF vs RSMDF: Fundamental Ratings
RSCF
RSMDF
OUTLOOK RATING
1..100
5031
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9237
PRICE GROWTH RATING
1..100
5990
P/E GROWTH RATING
1..100
392
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (30) in the null industry is somewhat better than the same rating for RSCF (68). This means that RSMDF’s stock grew somewhat faster than RSCF’s over the last 12 months.

RSMDF's Profit vs Risk Rating (99) in the null industry is in the same range as RSCF (100). This means that RSMDF’s stock grew similarly to RSCF’s over the last 12 months.

RSMDF's SMR Rating (37) in the null industry is somewhat better than the same rating for RSCF (92). This means that RSMDF’s stock grew somewhat faster than RSCF’s over the last 12 months.

RSCF's Price Growth Rating (59) in the null industry is in the same range as RSMDF (90). This means that RSCF’s stock grew similarly to RSMDF’s over the last 12 months.

RSCF's P/E Growth Rating (3) in the null industry is significantly better than the same rating for RSMDF (92). This means that RSCF’s stock grew significantly faster than RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCFRSMDF
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
42%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
31%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
33%
View a ticker or compare two or three
Interact to see
Advertisement
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IROH10.220.72
+7.58%
Iron Horse Acquisitions Corp
RCMT27.410.56
+2.09%
RCM Technologies
IRMD71.99-0.15
-0.21%
iRadimed Corp
AROC25.25-0.19
-0.75%
Archrock
OKE72.63-1.75
-2.35%
Oneok

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and MXCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
-8.83%
MXCT - RSCF
22%
Poorly correlated
+3.68%
BRSYF - RSCF
20%
Poorly correlated
N/A
RSMDF - RSCF
10%
Poorly correlated
N/A
RYLPF - RSCF
6%
Poorly correlated
N/A
PFGTF - RSCF
3%
Poorly correlated
N/A
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
-0.29%
PODD - RSMDF
25%
Poorly correlated
+0.57%
ANIK - RSMDF
25%
Poorly correlated
-1.65%
FLGT - RSMDF
25%
Poorly correlated
-0.14%
PACB - RSMDF
24%
Poorly correlated
+2.42%
More